Status:
UNKNOWN
A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery.
Lead Sponsor:
Precision Robotics (Hong Kong) Limited
Collaborating Sponsors:
Gleneagles Hospital
Queen Mary Hospital, Hong Kong
Conditions:
Ovarian Cancer
Cervical Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Precision Robotics' Sirius Robotic Flexible Endoscopic System is a new fully integrated compact 3D laparoscopic camera system with a disposable single-use flexible tip that can change its viewing dire...
Detailed Description
Minimally invasive surgery (MIS) is well established in gynecological surgery. Compared to laparotomy, MIS is associated with reduced morbidity and quicker recovery. With advancement in laparoscopic t...
Eligibility Criteria
Inclusion
- Patients who are planned for Laparoscopic Gynecological Surgery (LGS)
- Patient is 18 years of age or older
- Signed written informed consent.
Exclusion
- Patient is pregnant, or planning on becoming pregnant
- Obese patients (BMI \>35)
- Patient with known contraindication(s) to Laparoscopic Gynecological Surgery
- Patient with operations planned for longer than 4 hours
- Subjects are considered ineligible for the study as judged by the investigator.
Key Trial Info
Start Date :
January 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05318625
Start Date
January 10 2023
End Date
July 1 2024
Last Update
August 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gleneagles Hospital Hong Kong
Wong Chuk Hang, Hong Kong